Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Cash from Investing Activities (2012 - 2026)

Zoetis' (ZTS) quarterly Cash from Investing Activities came in at -$300.0 million in Q2 2026, down 41.51% year-over-year from -$512.9 million in Q2 2025, and down 244.83% quarter-over-quarter from -$87.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Cash from Investing Activities for 15 consecutive years, with -$300.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 41.51% year-over-year to -$300.0 million in Q2 2026; TTM through Jun 2026 was -$720.0 million, a 54.18% decrease from a year earlier, with the FY2025 full-year figure at -$748.0 million, down 137.46% from the prior year.
  • Cash from Investing Activities was -$300.0 million for Q2 2026 at Zoetis, down from -$87.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $126.0 million in Q4 2024 and troughed at -$438.0 million in Q4 2022.
  • A 5-year average of -$172.8 million and a median of -$172.5 million in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities surged 160.0% in 2024 and slumped 231.75% in 2025, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$438.0 million in 2022, then jumped by 52.05% to -$210.0 million in 2023, then surged by 160.0% to $126.0 million in 2024, then tumbled by 231.75% to -$166.0 million in 2025, then sank by 80.72% to -$300.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$300.0 million (Q2 2026), -$87.0 million (Q1 2026), and -$166.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn -25.50 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn -300.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn -110.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn -16.45 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -55,116.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -300.00 Mn
Mar 31, 2026 -87.00 Mn
Dec 31, 2025 -166.00 Mn
Sep 30, 2025 -167.00 Mn
Jun 30, 2025 -212.00 Mn
Mar 31, 2025 -203.00 Mn
Dec 31, 2024 126.00 Mn
Sep 30, 2024 -178.00 Mn
Jun 30, 2024 -132.00 Mn
Mar 31, 2024 -131.00 Mn
Dec 31, 2023 -210.00 Mn
Sep 30, 2023 -271.00 Mn
Jun 30, 2023 -80.00 Mn
Mar 31, 2023 -216.00 Mn
Dec 31, 2022 -438.00 Mn
Sep 30, 2022 -124.00 Mn
Jun 30, 2022 -203.00 Mn
Mar 31, 2022 -118.00 Mn
Dec 31, 2021 -142.00 Mn
Sep 30, 2021 -114.00 Mn